Description

Asthma is a major noncommunicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children. Asthma is caused by swelling (inflammation) of the breathing tubes that carry air in and out of the lungs. This makes the tubes highly sensitive, so they temporarily narrow. The global asthma drug market is poised to grow by US$ 6.8 billion during 2022-2028, progressing at a CAGR of 4.2% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for asthma drug. The global asthma drug market is segmented on the basis of medication, route of administration, distribution channel, and region. By medication, the global asthma drug market has been segmented into quick-relief medications, long-term control medications. Based upon route of administration, the global asthma drug market is categorized into inhaled, prefilled syringe/vials, others. On the basis of distribution channel, the global asthma drug market has been segmented into online pharmacies, hospitals, retail pharmacies. Geographically, the global asthma drug market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global asthma drug market is highly competitive. Key companies profiled in the report include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co. Inc., Novartis International AG, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the asthma drug market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Medication: quick-relief medications, long-term control medications
Route of administration: inhaled, prefilled syringe/vials, others
Distribution channel: online pharmacies, hospitals, retail pharmacies
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global asthma drug market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Asthma drug market overview
Part 3. Market breakdown by medication
– Quick-relief medications
– Long-term control medications
Part 4. Market breakdown by route of administration
– Inhaled
– Prefilled syringe/vials
– Others
Part 5. Market breakdown by distribution channel
– Online pharmacies
– Hospitals
– Retail pharmacies
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Abbott Laboratories
– AstraZeneca plc
– Boehringer Ingelheim International GmbH
– GlaxoSmithKline plc
– Koninklijke Philips N.V.
– Merck & Co., Inc.
– Novartis International AG
– Pfizer Inc.
– Sanofi S.A.
– Teva Pharmaceutical Industries Ltd.
About StrategyHelix
Disclaimer